There are nutrients most people have heard of — vitamin C, vitamin D, magnesium, omega-3. And then there are things happening inside your body that almost nobody talks about until something goes wrong. Nitric oxide is in that second category.
Nitric oxide (NO) is not a supplement. It's a molecule your body produces — specifically, by the cells lining your blood vessels. It's one of the primary mechanisms by which your vascular system regulates itself. And beginning as early as your 30s and accelerating after 40, nitric oxide production naturally decreases. These are not sudden changes — they are gradual shifts in vascular biology that compound over decades.
This article explains what nitric oxide does, why its decline matters, what the research shows about supporting NO levels through diet and supplementation, and — crucially — what is and isn't an authorised health claim. As always: consult your GP about cardiovascular health concerns. Food supplements are not medicines.
What Is Nitric Oxide and What Does It Do?
Nitric oxide is a small gaseous signalling molecule produced primarily by endothelial cells — the thin layer of cells that line the inside of your blood vessels. It is synthesised from the amino acid L-arginine by an enzyme called nitric oxide synthase (NOS).
Its primary function is vasodilation — it causes the smooth muscle in blood vessel walls to relax, allowing vessels to widen and blood to flow more freely. But NO does considerably more than that:
Causes blood vessels to relax and widen — improving circulation to muscles, organs and the brain
Vasodilation reduces peripheral resistance — a key mechanism in blood pressure regulation
Inhibits platelet aggregation and smooth muscle cell proliferation — factors in atherosclerosis
Improves oxygen delivery to working muscles — relevant to endurance and recovery
Acts as a neurotransmitter in the central nervous system — involved in memory and neural signalling
Produced by immune cells as part of the defence against pathogens — has antimicrobial properties
What Happens to Nitric Oxide After 40?
This is where it gets important for anyone in midlife. NO production doesn't stay constant — it declines progressively with age, and the decline begins earlier than most people realise.
2025 RESEARCH — PUBLISHED DECEMBER 2025
Accumulating evidence suggests that diminished NO bioavailability contributes to endothelial dysfunction, vascular stiffening and impaired cardiac performance — hallmarks of cardiovascular ageing. Reduced NO bioavailability with age stems from impaired endothelial and neuronal NO synthase activity, increased oxidative stress and metabolic shifts that drive cardiovascular decline.
Source: Declining nitric oxide bioavailability in cardiovascular ageing — comprehensive review, published December 2025
Endothelium-dependent dilation was significantly lower in older men (aged 62±1 years) compared to younger men (aged 21±1 years) — 10.2 vs 14.7 ml/100ml/min respectively — a finding from a study examining 56 healthy men aged 18–78 via brachial artery endothelial cells. The research found that as eNOS activity declined with age, endothelin-1 (a vasoconstrictor) increased — effectively tipping the balance from vasodilation toward vasoconstriction.
The mechanisms driving this decline include: reduced expression of eNOS (the enzyme that produces NO in blood vessels); increased oxidative stress that destroys NO before it can act; elevated ADMA (asymmetric dimethylarginine — a natural inhibitor of NOS that rises with age); and depletion of BH4 (a cofactor required for NOS to function properly). The result is what researchers call "endothelial dysfunction" — reduced ability of blood vessels to dilate in response to demand.
Why Does This Matter for People Over 40?
Endothelial dysfunction — the reduced ability to produce nitric oxide — is now recognised as an early marker of cardiovascular ageing. It precedes and contributes to conditions including hypertension, atherosclerosis and reduced exercise capacity. It doesn't cause symptoms you'd immediately notice. That's what makes it worth thinking about before problems develop.
Higher resting blood pressure — as vessels lose their ability to dilate, peripheral resistance increases
Reduced exercise capacity — less oxygen delivered to working muscles means earlier fatigue
Arterial stiffness — blood vessels lose elasticity, increasing the workload on the heart
Slower recovery — reduced blood flow to muscles affects repair and recovery after exertion
⚠️ None of the above are food supplement claims. If you have cardiovascular concerns — high blood pressure, chest pain, breathlessness, or a family history of heart disease — consult your GP. Supplements do not treat, manage or prevent cardiovascular disease.
What Does the Research Say About Supporting NO Levels?
There are three main evidence-based approaches the research has examined: dietary nitrates, exercise, and amino acid supplementation (L-arginine and L-citrulline). All three are research associations — none carry authorised EU/UK health claims for nitric oxide production specifically.
🥬 1. Dietary Nitrates (Beetroot, Spinach, Rocket)
Dietary nitrates — found in beetroot, spinach, rocket, celery and leafy greens — are converted to nitrite by bacteria in the mouth, and then to NO in the body via a NOS-independent pathway. This matters because NO can also be produced by the reduction of nitrate and nitrite, derived from dietary sources or from the oxidation of NOS-derived NO — a pathway that becomes increasingly important as direct NOS activity declines with age.
Beetroot juice is the most studied dietary source in clinical research, with multiple trials examining effects on blood pressure and exercise performance. The 2025 cardiovascular ageing review highlights dietary nitrate supplementation as one of the emerging interventions that may restore NO signalling.
🏃 2. Exercise — The Most Powerful NO Booster
Exercise — particularly aerobic exercise — is the most potent stimulus for eNOS activity. Physical shear stress on blood vessel walls during exercise directly upregulates eNOS expression. Research consistently shows that regular aerobic exercise attenuates the age-related decline in NO production and improves endothelial function in older adults.
The 2025 cardiovascular ageing review specifically cites exercise as one of three key interventions for restoring NO signalling alongside dietary nitrates and caloric restriction. This is the most evidence-backed approach and doesn't require a supplement.
💊 3. L-Arginine and L-Citrulline Supplementation
Both supplements were associated with improved endothelial-dependent vasodilation and moderate blood pressure reductions, especially at daily doses ≥6g. This comes from a comprehensive 2025 review of L-citrulline and L-arginine in cardiovascular and exercise physiology.
The arginine-NO pathway is direct: L-arginine → nitric oxide synthase (NOS) → nitric oxide. L-citrulline takes an indirect but often more effective route — L-citrulline has emerged as a better alternative to L-arginine supplementation because it can be well-absorbed and elevates L-arginine bioavailability and NO-dependent signalling to a greater extent compared to supplementing directly with L-arginine. When L-arginine is supplemented directly, it is subjected to significant catabolism in the gut and through first-pass metabolism which limits its systemic availability.
A 2025 RCT (Selvaraj et al., Scientific Reports) examined combined L-arginine and citrulline malate supplementation in trained adults across aerobic, anaerobic and CrossFit exercise protocols — finding that citrulline can potentially enhance and prolong arginine availability, thereby amplifying NO-mediated vasodilation, nutrient delivery and muscle performance during exercise.
⚠️ Important compliance note: L-arginine and L-citrulline have no authorised EU/UK health claims for nitric oxide production, blood pressure or cardiovascular function as food supplements. All content above is educational research context only — not product claims. Food supplement — not a medicine.
L-Arginine vs L-Citrulline — What's the Difference?
| Feature | L-Arginine | L-Citrulline |
|---|---|---|
| Role in NO pathway | Direct substrate for NOS enzyme | Converted to L-arginine in kidneys |
| Bioavailability | Significant gut and first-pass catabolism limits absorption | Higher — bypasses gut catabolism |
| Blood pressure research | Stronger direct evidence base | Good — especially ≥6g dose |
| Exercise performance | Inconsistent evidence | Clearer advantage in research |
| Combined use | ✅ Combined L-arg + L-citrulline may produce synergistic effects — each supports the pathway from different angles. PubMed 25445598 | |
| Authorised UK claims | ❌ None for NO production, blood pressure or cardiovascular function as food supplements | |
5 Evidence-Based Ways to Support Nitric Oxide Production After 40
Our Nitric Oxide Support Range
Food supplements — not medicines. Research associations only — no authorised EU/UK health claims for NO production. Consult your GP before use.
"I've been buying from Charge for about 7 or 8 years by now, and I can assure you everything I've bought is high quality with prompt delivery."
"Been ordering from you for years and recommending you — your service, delivery, packaging and product are of high standards."
"Ultra fast delivery and good quality product."
📚 Research References
Educational context only. Not health claims. All sources openly linked.
Patel (2025) — Declining NO bioavailability in cardiovascular ageing · Published Dec 2025
oaepublish.com/articles/jca.2025.14 →Comprehensive Review (2025) — L-Citrulline and L-Arginine in cardiovascular and exercise physiology · Published Nov 2025
ResearchGate 397507893 →Selvaraj et al. (2025) — Combined L-arginine and citrulline malate on exercise performance · Scientific Reports
PubMed 41006371 →Zain AlShanableh & Ray (2024) — Magnesium in hypertension: mechanisms and clinical implications · Frontiers in Physiology
Frontiers in Physiology →Taddei et al. (2009) — Vascular endothelial dysfunction with ageing · American Journal of Physiology
AJP Heart →Schwedhelm et al. (2008) — Pharmacokinetics of L-citrulline and L-arginine · British Journal of Clinical Pharmacology
PubMed 25445598 →Golbidi & Laher (2013) — Exercise and the ageing endothelium · Journal of Aging Research
PMC 3747387 →
